Towards molecular and phenotypic characterization of VEXAS syndrome

VEXAS syndrome is a rare, adult-onset, life-threatening autoinflammatory disease caused by a genetic mutation. The pathophysiology is still unknown, but new work presented at the 2024 congress of EULAR—The European Alliance of Associations for Rheumatology—aims to provide a molecular and phenotypic characterization of hematopoiesis in VEXAS patients, and to develop cellular and humanized mouse models by gene editing.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup